Empirico

Empirico is a biotechnology company that powers therapeutic discovery with human genetics and small interfering RNA (siRNA) medicines. Combining internal capabilities in human genetics and siRNA chemistry with partner expertise, the company identifies naturally occurring genetic variations associated with health benefits and develops precision oligonucleotide therapeutics for common diseases with significant unmet medical need. In October 2024 Empirico entered a licensing agreement with GSK worth up to $745 million for a clinical-stage oligonucleotide targeting respiratory disease (COPD). Empirico is backed by DCVC. It is a pharmaceutical R&D company and does not operate a public technology or API platform.

Empirico is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Human Genetics.

Empirico’s developer surface includes product news and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub

7.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyBiotechnologyPharmaceuticalsDrug DiscoveryHuman GeneticssiRNATherapeuticsLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 7.9/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.5 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/empirico: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 5

The organization behind the API

Website

About

News

Careers

LinkedIn

Source (apis.yml)

aid: empirico
name: Empirico
description: Empirico is a biotechnology company that powers therapeutic discovery with human genetics and small interfering
  RNA (siRNA) medicines. Combining internal capabilities in human genetics and siRNA chemistry with partner expertise, the
  company identifies naturally occurring genetic variations associated with health benefits and develops precision oligonucleotide
  therapeutics for common diseases with significant unmet medical need. In October 2024 Empirico entered a licensing agreement
  with GSK worth up to $745 million for a clinical-stage oligonucleotide targeting respiratory disease (COPD). Empirico is
  backed by DCVC. It is a pharmaceutical R&D company and does not operate a public technology or API platform.
url: https://raw.githubusercontent.com/api-evangelist/empirico/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.empiri.co/wp-content/uploads/2023/11/logo-empirico.svg
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Human Genetics
- siRNA
- Therapeutics
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.empiri.co/
- type: About
  url: https://www.empiri.co/our-company/
- type: News
  url: https://www.empiri.co/investors-news/
- type: Careers
  url: https://www.empiri.co/careers/
- type: PrivacyPolicy
  url: https://www.empiri.co/privacy-policy/
- type: TermsOfService
  url: https://www.empiri.co/terms-of-use/
- type: LinkedIn
  url: https://www.linkedin.com/company/empiricoinc/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence